Dimopoulos, M. A., Stewart, A. K., Masszi, T., Špička, I., Oriol, A., Hájek, R., . . . Palumbo, A. (2017). Carfilzomib–lenalidomide–dexamethasone vs lenalidomide–dexamethasone in relapsed multiple myeloma by previous treatment. Blood Cancer J.
Chicago Stili AlıntıDimopoulos, M A., et al. "Carfilzomib–lenalidomide–dexamethasone Vs Lenalidomide–dexamethasone in Relapsed Multiple Myeloma By Previous Treatment." Blood Cancer J 2017.
MLA AlıntıDimopoulos, M A., et al. "Carfilzomib–lenalidomide–dexamethasone Vs Lenalidomide–dexamethasone in Relapsed Multiple Myeloma By Previous Treatment." Blood Cancer J 2017.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..